Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.

Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, 'P134 Cell Injection,' which has received Investigational New Drug (IND) ...

A doctor from Shanghai Ruijin Hospital discusses the latest clinical use of China's first domestically produced proton ...

Fei Aihua (L), an endocrinologist at the Anhui Acupuncture and Moxibustion Hospital offers Traditional Chinese Medicine (TCM) therapy to a citizen at ...

Breast cancer subtyping is essential for determining appropriate treatment strategies, as each molecular category, luminal A, ...

Yang Libai (L, Front), leader of the 20th Chinese medical team for Malta, offers health consultations to a woman in Santa Venera, Malta, on April 15, 2025. Elderly people at the Santa Venera day care ...

Findings could open up new avenue for precision therapy for the most commonly diagnosed cancer among women that killed 670,000 in 2022 alone.

Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

India has introduced advanced Parkinson’s treatments like apomorphine injections and infusion pumps, while local researchers ...

Lanna Thai Traditional Massage is one of the first few practitioners of this ancient craft in Singapore. With their massage, ...